Brain Delivery of IGF1R5, a Single-Domain Antibody Targeting Insulin-like Growth Factor-1 Receptor

The ability of drugs and therapeutic antibodies to reach central nervous system (CNS) targets is greatly diminished by the blood–brain barrier (BBB). Receptor-mediated transcytosis (RMT), which is responsible for the transport of natural protein ligands across the BBB, was identified as a way to inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yogi, Alvaro, Hussack, Greg, van Faassen, Henk, Haqqani, Arsalan S., Delaney, Christie E., Brunette, Eric, Sandhu, Jagdeep K., Hewitt, Melissa, Sulea, Traian, Kemmerich, Kristin, Stanimirovic, Danica B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316817/
https://www.ncbi.nlm.nih.gov/pubmed/35890347
http://dx.doi.org/10.3390/pharmaceutics14071452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316817/
https://www.ncbi.nlm.nih.gov/pubmed/35890347
http://dx.doi.org/10.3390/pharmaceutics14071452

Ejemplares similares